Back to state act
Description
On 9 March 2020, the Norwegian Medicines Agency introduced a notification requirement on exports of 21 pharmaceutical goods following the COVID-19 outbreak. The pharmaceutical goods were the first to ...
Sign in to see full description
Intervention Details
Intervention Type
Export licensing requirement
MAST Chapter
P: Export-related measures (incl. subsidies)
Implementation date
09 Mar 2020
Revocation date
01 Jul 2023
Implementation level
National
Affected flow
Outward
Announced as temporary
Yes
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 16 products
Threads
See all
This intervention is not part of any Thread yet.